HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of chlorine-induced lung injury by the type 4 phosphodiesterase inhibitor rolipram.

Abstract
Chlorine is a highly toxic respiratory irritant that when inhaled causes epithelial cell injury, alveolar-capillary barrier disruption, airway hyperreactivity, inflammation, and pulmonary edema. Chlorine is considered a chemical threat agent, and its release through accidental or intentional means has the potential to result in mass casualties from acute lung injury. The type 4 phosphodiesterase inhibitor rolipram was investigated as a rescue treatment for chlorine-induced lung injury. Rolipram inhibits degradation of the intracellular signaling molecule cyclic AMP. Potential beneficial effects of increased cyclic AMP levels include inhibition of pulmonary edema, inflammation, and airway hyperreactivity. Mice were exposed to chlorine (whole body exposure, 228-270 ppm for 1 h) and were treated with rolipram by intraperitoneal, intranasal, or intramuscular (either aqueous or nanoemulsion formulation) delivery starting 1h after exposure. Rolipram administered intraperitoneally or intranasally inhibited chlorine-induced pulmonary edema. Minor or no effects were observed on lavage fluid IgM (indicative of plasma protein leakage), KC (Cxcl1, neutrophil chemoattractant), and neutrophils. All routes of administration inhibited chlorine-induced airway hyperreactivity assessed 1 day after exposure. The results of the study suggest that rolipram may be an effective rescue treatment for chlorine-induced lung injury and that both systemic and targeted administration to the respiratory tract were effective routes of delivery.
AuthorsWeiyuan Chang, Jing Chen, Connie F Schlueter, Roy J Rando, Yashwant V Pathak, Gary W Hoyle
JournalToxicology and applied pharmacology (Toxicol Appl Pharmacol) Vol. 263 Issue 2 Pg. 251-8 (Sep 01 2012) ISSN: 1096-0333 [Electronic] United States
PMID22763362 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2012 Elsevier Inc. All rights reserved.
Chemical References
  • Emulsions
  • Phosphodiesterase 4 Inhibitors
  • Chlorine
  • Cyclic AMP
  • Rolipram
Topics
  • Acute Lung Injury (chemically induced, drug therapy, physiopathology)
  • Administration, Intranasal
  • Animals
  • Bronchial Hyperreactivity (chemically induced, drug therapy)
  • Chlorine (toxicity)
  • Cyclic AMP (metabolism)
  • Emulsions
  • Inhalation Exposure
  • Injections, Intramuscular
  • Injections, Intraperitoneal
  • Mice
  • Nanoparticles
  • Phosphodiesterase 4 Inhibitors (administration & dosage, pharmacology)
  • Rolipram (administration & dosage, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: